Purchase our ophthalmology module on a standalone basis or together with other modules and solutions across our full portfolio to create an integrated, tailor-made research platform.
The ophthalmology pharmaceutical market addresses both age-associated diseases, such as macular degeneration, and common information-age maladies, such as dry-eye syndrome.
Both patient groups will continue to grow globally as the population ages and emerging markets industrialize. Additionally, diabetics, whose numbers are also increasing rapidly, are more prone to ophthalmic conditions. These factors suggest that there is a strong global market potential for ophthalmologic therapies.
GlobalData's therapy module includes coverage from prevalent diseases such as glaucoma to niche indications such as choroidal neovascularization.